• Resize Text
    • Small Text
    • Medium Text
    • Large Text
    • Connect
Gastro-intestinal System
Gastro-intestinal System

Cimetidine Oral Solution

Cimetidine is a histamine H₂ receptor antagonist.

Cimetidine Oral Solution is indicated for:

Cimetidine is indicated in the treatment of duodenal and benign gastric ulceration, including that associated with non-steroidal anti-inflammatory agents, recurrent and stomal ulceration, oesophageal reflux disease and other conditions where reduction of gastric acid by cimetidine has been shown to be beneficial: persistent, dyspeptic symptoms with or without ulceration, particularly meal-related upper abdominal pain, including such symptoms associated with non-steroidal anti-inflammatory agents; the prophylaxis of gastro-intestinal haemorrhage from stress ulceration in seriously ill patients; before general anaesthesia in patients thought to be at risk of acid aspiration (Mendelson’s) syndrome, particularly obstetric patients during labour; to reduce malabsorption and fluid loss in the short bowel syndrome; and in pancreatic insufficiency to reduce degradation of enzyme supplements. Cimetidine is also recommended in the management of the Zollinger-Ellison syndrome.

Icon respresenting a network

Summary of Product Characteristics

Read this summary of product characteristics for further information about Cimetidine Oral Solution. Click below to navigate to the EMC.

More info
Icon respresenting a person

Patient Information Leaflet

Read this patient information leaflet about Cimetidine Oral Solution, what it’s used for and possible side effects. Click below to navigate to the EMC.

More info
Gastro-intestinal System

Cimetidine Oral Solution

Rosemont Pharmaceuticals - Cimentide
Click here for Audio Version
Flavour Peach and peppermint
Storage Conditions Do not store above 25°C
Sucrose Free
Shelf Life (Closed Bottle/Open Bottle) 18 months / 1 month
PIP Code 110-3134
EAN Code 50-16119-17139-0
Sodium Levels Essentially sodium-free
Ethanol Concentration None

Downloads

Adverse Events

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk
Adverse events should also be reported to Rosemont at 0113 244 1400 or pharmacovigilance@rosemontpharma.com.

Rosemont Pharmaceuticals - World Map icon

Contact us

For further product information and pricing please use the form below and a member of the team will be in touch






    Please prove you are human by selecting the truck.

    Stay updated via our App

     

    A new Rosemont Pharmaceuticals App for Healthcare Professionals is launching soon.

    Rosemont app on a mobile device

    Gastro-intestinal System

    Rosemont Pharmaceuticals - Cimentide

    Cimetidine Oral Solution